Invention Grant
- Patent Title: Arginase inhibitors and methods of use
-
Application No.: US16973623Application Date: 2019-06-14
-
Publication No.: US11274111B2Publication Date: 2022-03-15
- Inventor: Abdelghani Abe Achab , Jared N. Cumming , Christian Fischer , Symon Gathiaka , Charles A. Lesburg , Derun Li , Min Lu , Matthew J. Mitcheltree , Anandan Palani , Rachel L. Palte , David L. Sloman , Hongjun Zhang
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Janet E. Fair; Alysia Finnegan
- International Application: PCT/US2019/037140 WO 20190614
- International Announcement: WO2019/245890 WO 20191226
- Main IPC: C07F5/02
- IPC: C07F5/02 ; C07K16/28
Abstract:
Described herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds of Formula (I) act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
Public/Granted literature
- US20210163505A1 ARGINASE INHIBITORS AND METHODS OF USE Public/Granted day:2021-06-03
Information query
